Liqin Wei – Trademark Portfolio

Entity Type: 01

Liqin Wei holds 6 U.S. trademarks filed with the United States Patent and Trademark Office (USPTO), with a strong focus on Class 25 (Clothing) — 3 filings in this category. The portfolio also extends into Class 12 (Vehicles) across 2 Nice Classification classes. Currently, 5 trademarks are registered and 1 is pending. Notable registered marks include TOIMEX, CYBROOT, MIRSEAD, RIVOVUS, and TERASTEP. The owner is based in Shangrao City, Jiangxi Province.

NO.032, Weishan Village, Xiangshuitan Township, Poyang County,

Shangrao City, Jiangxi Province 333100 , CN

6 Total Trademarks

Add to watchlist:

No watchlists yet
Loading...
By Date
By Name
Filter by Class:

TERASTEP
TERASTEP
Registered 2026
RIVOVUS
RIVOVUS
Registered 2026
TOIMEX
TOIMEX
Registered 2026
MIRSEAD
MIRSEAD
Registered 2026
CYBROOT
CYBROOT
Registered 2026
APEXIR
APEXIR
Pending 2026

Trademark Classifications

Liqin Wei's trademark portfolio spans 2 Nice Classification classes, reflecting the scope of goods and services protected under their brand portfolio.

25
Clothing (3 filings)

Clothing, footwear, headgear

12
Vehicles (3 filings)

Vehicles; apparatus for locomotion by land, air or water

Frequently Asked Questions

How many trademarks does Liqin Wei have?

Liqin Wei has 6 U.S. trademarks filed with the USPTO. Of these, 5 registered, 1 pending.

What trademark classes does Liqin Wei file in?

Liqin Wei files trademarks across 2 Nice Classification classes. The most active classes are Class 25 (Clothing), Class 12 (Vehicles). Class 25 covers clothing, footwear, headgear.

What are Liqin Wei's most well-known trademarks?

Liqin Wei's registered trademark portfolio includes well-known marks such as TOIMEX, CYBROOT, MIRSEAD, RIVOVUS, and TERASTEP. These are among 5 currently registered trademarks in the portfolio.

What is Liqin Wei's trademark registration success rate?

Liqin Wei has a 100% trademark registration rate, with 5 out of 5 resolved applications resulting in successful registration. Currently, 1 application is pending review.